Monday, October 17, 2011 12:24:25 AM
http://www.pharmacyboardkenya.org/assets/files/Clinical_Trial_Guidelines04_03_2011.pdf
AQLV should have no problems involving themselves with these people if in fact what they are trying to impress upon the public is valid. In fact, communication might be encouraged by anyone with this group about AQLV, the company and/or it's product or just means to research the subject matter. At any rate, the web site is quite informative and worth a look around.
http://www.iavi.org/working-with-communities/country-programs/Pages/kenya.aspx
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • Oct 10, 2024 8:09 AM
FEATURED CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM